Physician profile
Prabodh M Mehta
NPI 1982606604
$132,796.59
in general payments reported to CMS, 2019-2025
38 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,562 · 2020: $8,540 · 2021: $21K · 2022: $14K · 2023: $70K · 2024: $18K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $53K · Travel and Lodging: $32K · Food and Beverage: $1,508 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $53,348.75 |
| Travel and Lodging | $32,499.54 |
| Food and Beverage | $1,508.01 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $99,976.21 | 2021-2024 | Verquvo |
| Esperion Therapeutics, INC. | $18,149.82 | 2021-2022 | |
| Astrazeneca Pharmaceuticals Lp | $10,714.85 | 2019-2024 | Farxiga, Brilinta, Andexxa |
| Terumo Medical Corporation | $700.04 | 2019 | |
| Abbott Laboratories | $699.89 | 2019-2024 | Thoratec Heartmate 3 Lvas Implant Kit |
| Novartis Pharmaceuticals Corporation | $400.95 | 2019-2024 | |
| Amgen INC. | $358.63 | 2019-2023 | Repatha |
| Janssen Pharmaceuticals, INC | $318.89 | 2019-2022 | |
| Pfizer INC. | $165.19 | 2022-2024 | |
| Boston Scientific Corporation | $150.46 | 2021-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $139.04 | 2019-2023 | Lifevest |
| Amarin Pharma, INC. | $126.29 | 2019-2021 | |
| Chiesi USA, INC. | $125.22 | 2019-2022 | |
| Cardiovascular Systems INC. | $102.83 | 2020 | |
| Alnylam Pharmaceuticals INC. | $77.61 | 2021-2024 | Onpattro |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $74.10 | 2019-2022 | |
| Lundbeck LLC | $69.33 | 2019-2020 | |
| Astellas Pharma US INC | $66.78 | 2019-2021 | |
| Lexicon Pharmaceuticals, INC. | $51.30 | 2023-2024 | Inpefa |
| Boehringer Ingelheim Pharmaceuticals, INC. | $38.39 | 2021-2022 | |
| Acist Medical Systems, INC. | $32.48 | 2019 | |
| Novo Nordisk INC | $22.23 | 2019 | |
| Vifor Pharma, INC. | $20.97 | 2021 | |
| Inari Medical, INC. | $19.89 | 2022 | |
| Medtronic Vascular, INC. | $18.58 | 2020 | |
| Actelion Pharmaceuticals US, INC. | $16.42 | 2020 | |
| Teleflex LLC | $15.96 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.94 | 2024 | |
| Otsuka America Pharmaceutical, INC. | $15.03 | 2019 | |
| Portola Pharmaceuticals, LLC | $14.60 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $14.23 | 2021 | |
| Kiniksa Pharmaceuticals, Ltd. | $12.85 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $12.55 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $11.98 | 2019 | |
| Arbor Pharmaceuticals, INC. | $11.94 | 2019 | |
| Verge Medical, INC. | $11.79 | 2020 | |
| Bardy Diagnostics, INC. | $11.67 | 2022 | |
| Elutia, INC. | $11.66 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Prabodh Mehta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.